Vitamin B5 supplementation reduced bone loss in mice with osteoporosis and stopped bone-eating cells from developing in laboratory studies, according to 2026 research published in Scientific Reports. The vitamin works by blocking a protein called PKM2 from entering cell nuclei, which prevents these cells from activating the energy-burning processes needed to break down bone. While these findings are promising, human clinical trials are needed to confirm whether vitamin B5 supplementation could help prevent osteoporosis in people.
According to research reviewed by Gram, scientists discovered that vitamin B5 (also called pantothenic acid) might help prevent osteoporosis, a disease where bones become weak and break easily. In a study using mice and lab cells, researchers found that vitamin B5 stopped special bone-eating cells called osteoclasts from working properly. When mice didn’t get enough vitamin B5, their bones got worse. When they got extra vitamin B5, their bones stayed stronger. The discovery involves how vitamin B5 changes the way these bone cells use energy, which could lead to new treatments for osteoporosis.
Key Statistics
A 2026 study published in Scientific Reports found that mice receiving vitamin B5 supplementation maintained significantly stronger bones and had fewer osteoclasts (bone-eating cells) compared to control mice with osteoporosis.
According to the 2026 research, vitamin B5 and its metabolic product CoA suppressed osteoclast differentiation in laboratory cell cultures without inducing cell death, suggesting a targeted biological effect.
The 2026 study demonstrated that vitamin B5 increases intracellular CoA levels in a PANK-dependent manner, which then reduces PKM2 nuclear translocation and suppresses both glycolytic and oxidative phosphorylation activity in bone-eating cells.
The Quick Take
- What they studied: Whether vitamin B5 can stop bone-eating cells from breaking down bone tissue and causing osteoporosis
- Who participated: Laboratory mice with osteoporosis (created by removing their ovaries to mimic menopause), plus lab-grown bone cells from mice
- Key finding: Mice given extra vitamin B5 had less bone loss and fewer bone-eating cells compared to mice without enough vitamin B5
- What it means for you: Vitamin B5 might become part of osteoporosis treatment, though human studies are still needed to confirm these lab findings work the same way in people
The Research Details
Researchers used two main approaches to study vitamin B5’s effects on bone health. First, they created osteoporosis in laboratory mice by removing their ovaries (similar to menopause in women) and fed different groups either low, normal, or high amounts of vitamin B5. They then took detailed pictures of the mice’s bones using special scanning technology to measure bone density and structure.
Second, they grew bone cells in laboratory dishes and tested how vitamin B5 affected their behavior. They used advanced techniques to measure how these cells used energy and tracked specific proteins involved in bone breakdown. This combination of whole-animal and cell-level studies helped them understand both whether vitamin B5 works and how it works.
The researchers also used computer modeling to predict how vitamin B5 molecules interact with specific proteins inside cells, and they confirmed these predictions with lab tests.
This research approach is important because it bridges the gap between basic science and real-world application. Testing in both living animals and isolated cells helps researchers understand if something works and why it works. The detailed energy measurements and protein tracking provide a clear mechanism—the biological pathway—that explains how vitamin B5 prevents bone loss, making the findings more credible and useful for developing future treatments.
This study was published in Scientific Reports, a peer-reviewed journal, meaning other scientists reviewed the work before publication. The researchers used multiple complementary techniques (imaging, cell biology, molecular analysis, and computer modeling) to confirm their findings from different angles. However, this is laboratory research in mice and cells, not human trials, so results may not translate directly to people. The study provides preliminary evidence that warrants further investigation in human subjects.
What the Results Show
Vitamin B5 supplementation significantly reduced bone loss in mice with osteoporosis. Mice receiving extra vitamin B5 maintained stronger bones and had fewer osteoclasts (bone-eating cells) compared to control mice. Conversely, mice fed a vitamin B5-deficient diet experienced accelerated bone deterioration, showing that adequate vitamin B5 is necessary for bone health.
In laboratory cell studies, both vitamin B5 and its metabolic product (CoA) suppressed the development of osteoclasts without killing the cells, suggesting a targeted effect rather than general toxicity. The cells treated with vitamin B5 showed reduced ability to break down bone material.
The mechanism involves vitamin B5 increasing levels of a molecule called CoA inside cells. This CoA then interacts with a protein called PKM2, preventing it from moving into the cell’s nucleus (control center). When PKM2 stays out of the nucleus, the bone-eating cells cannot activate their energy-burning processes needed for bone destruction.
The research showed that vitamin B5’s protective effect depends on a specific enzyme called PANK, which converts vitamin B5 into CoA. When researchers blocked this enzyme, vitamin B5 lost its protective effects. Additionally, when researchers artificially stabilized PKM2 protein, it partially reversed the beneficial effects of vitamin B5, confirming that PKM2 is a key target. The study also demonstrated that vitamin B5 reduced both glycolysis (one type of energy production) and oxidative phosphorylation (another type), suggesting it affects multiple energy pathways in bone-eating cells.
Previous research established that bone-eating cells switch to high-energy metabolism when they become active, similar to cancer cells. This study builds on that knowledge by identifying vitamin B5 as a specific nutritional factor that can interrupt this metabolic switch. While other nutrients have been studied for bone health, the specific mechanism involving the PANK-CoA-PKM2 pathway appears novel. The findings align with growing evidence that metabolic regulation is crucial for bone remodeling and that nutritional factors can influence this process.
This research was conducted entirely in laboratory settings (mice and cell cultures), not in human subjects, so results may not directly apply to people. The study doesn’t specify exact sample sizes for all experiments, making it difficult to assess statistical power. The research used an artificial osteoporosis model (ovariectomy-induced) that mimics menopause-related bone loss but may not represent all types of osteoporosis. Additionally, the study examined vitamin B5 supplementation levels that may differ from typical dietary intake, and it’s unclear whether dietary sources of vitamin B5 would produce the same effects. Long-term safety and optimal dosing in humans remain unknown.
The Bottom Line
Based on this preliminary research, maintaining adequate vitamin B5 intake appears important for bone health, though human clinical trials are needed before making specific supplementation recommendations. Current adequate intake levels (5 mg daily for adults) should be met through diet when possible. People at risk for osteoporosis should discuss bone health strategies with their healthcare provider, as this research is too early-stage to replace established osteoporosis treatments. Confidence level: Low to Moderate (laboratory evidence only).
This research is most relevant to people at risk for osteoporosis, including postmenopausal women, older adults, and those with family history of bone disease. Healthcare providers researching new osteoporosis prevention strategies should note these findings. People currently taking osteoporosis medications should not change their treatment based on this study. Those with vitamin B5 deficiency (rare in developed countries) may benefit from ensuring adequate intake.
If vitamin B5 supplementation proves effective in humans, benefits would likely develop gradually over months to years, similar to other bone health interventions. Bone remodeling is a slow process, so expecting immediate results would be unrealistic. Clinical trials would be needed to establish realistic timelines for human benefit.
Frequently Asked Questions
Can vitamin B5 supplements prevent osteoporosis?
Laboratory research shows vitamin B5 reduced bone loss in mice and stopped bone-eating cells in cell cultures, but human clinical trials haven’t been conducted yet. Current evidence is too preliminary to recommend supplementation as an osteoporosis treatment without consulting your doctor.
How much vitamin B5 do I need daily for bone health?
The recommended adequate intake is 5 mg daily for adults, typically met through foods like eggs, mushrooms, and chicken. The study used higher supplementation levels in mice, so it’s unclear if dietary amounts provide the same bone-protective effects seen in research.
What foods are high in vitamin B5?
Good sources include eggs, mushrooms, avocados, chicken, beef, sunflower seeds, and fortified grains. Most people in developed countries get adequate vitamin B5 from a balanced diet, as deficiency is rare.
Is this research applicable to humans with osteoporosis?
This study used laboratory mice and cell cultures, not human subjects. While the findings are promising and suggest a biological mechanism worth investigating, human clinical trials are necessary before recommending vitamin B5 supplementation for osteoporosis treatment.
Should I stop my osteoporosis medication and take vitamin B5 instead?
No. This research is preliminary laboratory evidence, not a replacement for established osteoporosis treatments. Continue taking prescribed medications and discuss any changes with your healthcare provider before adding supplements.
Want to Apply This Research?
- Track daily vitamin B5 intake in milligrams and correlate with bone health markers (if available through medical testing). Log sources: eggs, mushrooms, avocados, chicken, and fortified grains to monitor dietary intake patterns.
- Add one vitamin B5-rich food to your daily diet (such as an egg at breakfast, mushrooms in lunch, or avocado as a snack) and track consistency over 30 days. Set reminders to include these foods regularly.
- Maintain a 90-day log of vitamin B5-rich foods consumed and any bone-related symptoms or medical test results. Review monthly to identify patterns and ensure consistent intake of recommended sources.
This article summarizes laboratory research in mice and cell cultures. The findings have not been tested in human subjects, and vitamin B5 supplementation is not an established osteoporosis treatment. Do not change your osteoporosis medications or start new supplements based on this research without consulting your healthcare provider. This information is for educational purposes only and should not replace professional medical advice. People with existing bone disease, those taking medications, or anyone considering supplementation should discuss these findings with their doctor to determine if they’re appropriate for their individual situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.